These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21913264)

  • 1. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
    Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.
    Yang MH; Chu PY; Chen SC; Chung TW; Chen WC; Tan LB; Kan WC; Wang HY; Su SB; Tyan YC
    Biochem Biophys Res Commun; 2011 Aug; 411(4):714-20. PubMed ID: 21782798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
    Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
    J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker.
    Zhang Y; Li Y; Qiu F; Qiu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3395-401. PubMed ID: 21093387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].
    Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis.
    Sheng KH; Yao YC; Chuang SS; Wu H; Wu TF
    Proteomics; 2006 Feb; 6(3):1058-65. PubMed ID: 16400682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a comprehensive database of proteins from the urine of patients with bladder cancer.
    Rasmussen HH; Orntoft TF; Wolf H; Celis JE
    J Urol; 1996 Jun; 155(6):2113-9. PubMed ID: 8618346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder.
    Sánchez-Carbayo M; Herrero E; Megias J; Mira A; Espasa A; Chinchilla V; Soria F
    J Urol; 1999 Apr; 161(4):1110-5. PubMed ID: 10081849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry.
    Tyan YC; Wu HY; Lai WW; Su WC; Liao PC
    J Proteome Res; 2005; 4(4):1274-86. PubMed ID: 16083277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
    Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine.
    Li QR; Fan KX; Li RX; Dai J; Wu CC; Zhao SL; Wu JR; Shieh CH; Zeng R
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):823-32. PubMed ID: 20187088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
    Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
    Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of human urinary proteome using nano-high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Tyan YC; Guo HR; Liu CY; Liao PC
    Anal Chim Acta; 2006 Oct; 579(2):158-76. PubMed ID: 17723740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples.
    van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium.
    Niu HT; Zhang YB; Jiang HP; Cheng B; Sun G; Wang Y; E YJ; Pang de Q; Chang JW
    Urol Oncol; 2009; 27(4):400-6. PubMed ID: 18818109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine.
    Celis JE; Rasmussen HH; Vorum H; Madsen P; Honoré B; Wolf H; Orntoft TF
    J Urol; 1996 Jun; 155(6):2105-12. PubMed ID: 8618345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
    Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
    Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
    Svatek RS; Herman MP; Lotan Y; Casella R; Hsieh JT; Sagalowsky AI; Shariat SF
    Cancer; 2006 Apr; 106(8):1701-7. PubMed ID: 16541433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.